Paraventricular nucleus regulatory mechanisms in stress and hypertension

应激和高血压的室旁核调节机制

基本信息

  • 批准号:
    8116642
  • 负责人:
  • 金额:
    $ 40.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-08-01 至 2014-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): It is established that the central nervous system (CNS) contributes to the long-term regulation of blood pressure in both health and disease via effects on neuroendocrine mechanisms and sympathetic outflow. Specifically, elevations in baseline and stress-induced activation of the hypothalamic-pituitary-adrenal (HPA) axis activity and sympathetic nervous system function are implicated in the etiology of hypertension in humans and in related animal models including the spontaneously hypertensive rat (SHR). However, CNS mechanisms that mediate chronic increases in baseline blood pressure and/or stress reactivity are inadequately understood. The overall goal of our research program is to elucidate mechanisms within the brain that mediate chronic changes in baseline and stress-activated blood pressure regulation. The experiments in this application focus on regulatory mechanisms within the paraventricular nucleus (PVN) of the hypothalamus. Neurons within the PVN are critical to the central regulation of both the HPA axis and the sympathetic nervous system, and angiotensin II (Ang II) acting within the PVN has emerged as one key neuropeptide that can activate both of these outputs. We have recently identified macrophage migration inhibitory factor (MIF) as an intracellular negative regulator of the excitatory actions of Ang II in normotensive rat neurons. Collectively, our studies indicate that MIF acts within PVN neurons of normotensive rats via its intrinsic thiol protein oxidoreductase (TPOR) activity to attenuate the cardiovascular actions of Ang II. However, our data indicate this regulatory mechanism is absent from PVN neurons of SHR, and that long-term replacement of MIF within SHR neurons blunts the age-related increase in baseline blood pressure observed in this model of hypertension. These results establish an important role for MIF in attenuating the excitatory effects of Ang II, acting within the PVN, to promote age-related increases in baseline blood pressure. The present application specifically investigates the role of PVN MIF in the modulation of Ang II-mediated blood pressure regulation during acute and chronic stress, and potential contributions of both the HPA axis and the sympathetic nervous system to blood pressure regulation will be determined. The overall hypothesis is that replacement of MIF within PVN neurons of SHR will attenuate the increased blood pressure reactivity to stress observed in these animals by a mechanism that requires the TPOR activity of MIF. The specific goal is to test this hypothesis by utilizing AAV2-mediated gene delivery to chronically express MIF, or a mutant MIF protein that lacks TPOR activity, selectively in PVN neurons of SHR and normotensive control rats. This goal will be achieved via the following Specific Aims: Aim 1 is to determine the effects of long-term viral-mediated expression of MIF within PVN neurons of SHR and normotensive rats on blood pressure regulation during acute and chronic stress. Aim 2 is to determine the role of the TPOR moiety of MIF in mediating the effects of MIF within PVN neurons of SHR and normotensive rats on blood pressure regulation during acute and chronic stress. PUBLIC HEALTH RELEVANCE: Current treatment of high blood pressure primarily targets symptoms rather than causes or prevention because the causes of high blood pressure are not established. It is now understood that people who have a high level of stress in their lives and/or react excessively to stress have an increased risk for high blood pressure. The goal of the proposed studies is to show that macrophage migration inhibitory factor in the brain is a key regulator of blood pressure at rest and during stress, thus providing a novel target for the prevention and treatment of high blood pressure.
说明(申请人提供):已确定中枢神经系统(CNS)通过影响神经内分泌机制和交感神经流出,对健康和疾病的血压进行长期调节。具体地说,基线和应激诱导的下丘脑-垂体-肾上腺(HPA)轴活动和交感神经系统功能的升高与人类高血压的病因学以及包括自发性高血压大鼠(SHR)在内的相关动物模型有关。然而,中枢神经系统调节基线血压和/或应激反应性慢性升高的机制还不够清楚。我们研究计划的总体目标是阐明大脑中调节基线和应激激活血压调节的慢性变化的机制。在这一应用中的实验集中在下丘脑室旁核(PVN)内的调节机制。PVN内的神经元对HPA轴和交感神经系统的中枢调节都是至关重要的,而作用于PVN内的血管紧张素II(Ang II)已成为激活这两种输出的关键神经肽之一。我们最近发现巨噬细胞移动抑制因子(MIF)是Ang II在正常血压大鼠神经元兴奋作用的细胞内负调节因子。总之,我们的研究表明,MIF通过其内在的硫醇蛋白氧化还原酶(TpoR)活性作用于正常血压大鼠的PVN神经元,以减轻Ang II的心血管作用。然而,我们的数据表明,SHR的PVN神经元缺乏这种调节机制,长期在SHR神经元内替代MIF可以钝化这种高血压模型中观察到的与年龄相关的基础血压升高。这些结果证实了MIF在减弱血管紧张素转换酶II的兴奋效应方面的重要作用,血管紧张素转换酶II作用于室旁核,促进与年龄相关的基线血压升高。本申请专门研究PVN MIF在急、慢性应激时血管紧张素Ⅱ介导的血压调节中的作用,并将确定HPA轴和交感神经系统对血压调节的潜在贡献。总体假设是,在SHR的PVN神经元内替换MIF将通过一种需要MIF的TpoR活性的机制来减弱这些动物对应激的血压反应性增加。具体目的是通过利用AAV2介导的基因传递在SHR和正常血压对照组大鼠的PVN神经元中选择性地慢性表达MIF或缺乏TpoR活性的突变MIF蛋白来验证这一假说。这一目标将通过以下具体目标来实现:目的1确定病毒介导的MIF在SHR和正常血压大鼠PVN神经元中的长期表达对急、慢性应激时血压调节的影响。目的2探讨MIF的TpoR部分在介导SHR和正常血压大鼠PVN神经元MIF在急、慢性应激时血压调节中的作用。与公共卫生相关:目前对高血压的治疗主要针对症状,而不是原因或预防,因为高血压的病因尚未确定。现在人们了解到,生活中压力很大和/或对压力反应过度的人患高血压的风险更高。这项研究的目的是证明脑内巨噬细胞移动抑制因子是静息和应激时血压的关键调节因子,从而为高血压的预防和治疗提供新的靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

COLIN SUMNERS其他文献

COLIN SUMNERS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('COLIN SUMNERS', 18)}}的其他基金

Angiotensin-sensitive neurons in the nucleus of the solitary tract mediate social stress induced hypertension
孤束核中血管紧张素敏感神经元介导社会压力诱发的高血压
  • 批准号:
    10668569
  • 财政年份:
    2017
  • 资助金额:
    $ 40.45万
  • 项目类别:
Paraventricular nucleus regulatory mechanisms in stress and hypertension
应激和高血压的室旁核调节机制
  • 批准号:
    8293201
  • 财政年份:
    2009
  • 资助金额:
    $ 40.45万
  • 项目类别:
Paraventricular nucleus regulatory mechanisms in stress and hypertension
应激和高血压的室旁核调节机制
  • 批准号:
    7729905
  • 财政年份:
    2009
  • 资助金额:
    $ 40.45万
  • 项目类别:
Paraventricular nucleus regulatory mechanisms in stress and hypertension
应激和高血压的室旁核调节机制
  • 批准号:
    7903187
  • 财政年份:
    2009
  • 资助金额:
    $ 40.45万
  • 项目类别:
Paraventricular nucleus regulatory mechanisms in stress and hypertension
应激和高血压的室旁核调节机制
  • 批准号:
    8476247
  • 财政年份:
    2009
  • 资助金额:
    $ 40.45万
  • 项目类别:
MIF: A novel CNS regulator of cardiovascular function
MIF:心血管功能的新型中枢神经系统调节剂
  • 批准号:
    7102601
  • 财政年份:
    2005
  • 资助金额:
    $ 40.45万
  • 项目类别:
MIF: A novel CNS regulator of cardiovascular function
MIF:心血管功能的新型中枢神经系统调节剂
  • 批准号:
    8447494
  • 财政年份:
    2005
  • 资助金额:
    $ 40.45万
  • 项目类别:
MIF: A novel CNS regulator of cardiovascular function
MIF:心血管功能的新型中枢神经系统调节剂
  • 批准号:
    7239526
  • 财政年份:
    2005
  • 资助金额:
    $ 40.45万
  • 项目类别:
MIF: A novel CNS regulator of cardiovascular function
MIF:心血管功能的新型中枢神经系统调节剂
  • 批准号:
    8105814
  • 财政年份:
    2005
  • 资助金额:
    $ 40.45万
  • 项目类别:
MIF: A novel CNS regulator of cardiovascular function
MIF:心血管功能的新型中枢神经系统调节剂
  • 批准号:
    8261078
  • 财政年份:
    2005
  • 资助金额:
    $ 40.45万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 40.45万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 40.45万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 40.45万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 40.45万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 40.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 40.45万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 40.45万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 40.45万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 40.45万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 40.45万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了